Genome Editing/Genome Engineering Market Expected To Reach $24.52 Billion By 2030 As Growth Accelerates At 19.2% CAGR
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Genome Editing/Genome Engineering Market Growth Potential: How Will Market Size Change Through 2030?
The sector dedicated to genome editing and engineering has experienced significant expansion lately, with projections indicating a rise from $10.17 billion in 2025 to $12.15 billion in 2026, reflecting a compound annual growth rate of 19.5%. Factors fueling this past growth include the advent of genome editing methodologies, initial research applications, the proliferation of molecular biology instrumentation, increased investment in academic research, and a heightened need for disease modeling.
The field of genome editing, also referred to as genome engineering, is projected to experience substantial expansion in the upcoming years, reaching an estimated market value of $24.53 billion by 2030. This impressive growth trajectory is underpinned by a compound annual growth rate (CAGR) of 19.2%, fueled by several key drivers. These include the progression of gene editing therapies into clinical applications, the broadening scope of agricultural genomics, advancements leading to more precise editing capabilities, the establishment of ethical guidelines, and the increasing commercial availability of genome editing services. Furthermore, several significant trends are anticipated to shape this market during the forecast period, such as a greater reliance on CRISPR-based editing technologies, the expanding application of genome editing within disease research, a rise in the utilization of cell line engineering for various purposes, a growing need for highly accurate gene modification techniques, and increased investment in academic and governmental research initiatives.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp
Genome Editing/Genome Engineering Market Growth Drivers: What Factors Are Accelerating Expansion?
The expansion of the genome editing and genome engineering sector is anticipated to be propelled by a rise in scientific investigations. These investigations encompass structured endeavors undertaken by individuals, groups, or organizations aimed at acquiring, examining, interpreting, and producing novel understanding within a specific domain. Genome editing and engineering technologies are now central to the burgeoning volume of research, reshaping how scientific inquiry is conducted. Such advanced methodologies enable scientists to precisely alter and understand the complex genetic makeup of living things, providing exceptional accuracy and adaptability. For example, the National Institute of Neurological Disorders and Stroke, a US government research body, announced in July 2023 that the NIH was allocating over $140 million to expedite the translation of genome editing techniques from laboratory settings to clinical applications. Consequently, an escalation in research initiatives serves as a primary impetus for the growth of the genome editing and genome engineering market.
Genome Editing/Genome Engineering Market Segment Breakdown: Which Categories Generate The Most Revenue?
The genome editing/genome engineering market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Software And Systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes
Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects
Genome Editing/Genome Engineering Market Trends: What Is Shaping Future Industry Growth?
In the competitive landscape of genome editing and genome engineering, prominent entities frequently engage in alliances to enhance their market standing. Such strategic business partnerships signify formal cooperative arrangements among multiple commercial organizations, typically formalized through contractual agreements. An illustrative example occurred in April 2024 when Regeneron Pharmaceuticals, an American biopharmaceutical firm dedicated to pioneering treatments for immunological disorders, cancers, and genetic conditions, joined forces with Mammoth Biosciences, a US biotechnology enterprise co-founded by Jennifer Doudna and renowned for its specialization in CRISPR gene editing. Through this collaboration, Regeneron intends to harness Mammoth’s exceptionally compact CRISPR technologies alongside Regeneron’s established delivery systems to expedite the creation of in vivo gene editing interventions targeting tissues outside the liver, consequently broadening Regeneron’s scope of therapeutic offerings and technological capabilities. Mammoth Biosciences, a company headquartered in the United States, furnishes CRISPR-driven genome editing solutions, encompassing its proprietary compact Cas enzymes, for both therapeutic and diagnostic purposes.
Genome Editing/Genome Engineering Market Key Players And Strategic Industry Positioning
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.
Access The Complete Genome Editing/Genome Engineering Market Report:
Genome Editing/Genome Engineering Market Regional Analysis: Which Region Leads By Revenue?
North Americawas the largest region in the gene editing/genome engineering market in 2025. Asia-Pacificis expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
